Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results

Myriad Genetics (MYGN) Misses Q1 EPS by 2c; Maintains Outlook

November 1, 2016 4:15 PM EDT

Myriad Genetics (NASDAQ: MYGN) reported Q1 EPS of $0.23, $0.02 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $177.5 million versus the consensus estimate of $172.85 million.

GUIDANCE:

Myriad Genetics sees Q2 2017 EPS of $0.23-$0.25, versus the consensus of... More